Cargando…
Regulatory mechanisms of Robo4 and their effects on angiogenesis
Roundabout4 (Robo4) is a transmembrane receptor that belongs to the Roundabout (Robo) family of axon guidance molecules. Robo4 is an endothelial-specific receptor that participates in endothelial cell migration, proliferation, and angiogenesis and the maintenance of vasculature homeostasis. The purp...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620384/ https://www.ncbi.nlm.nih.gov/pubmed/31160487 http://dx.doi.org/10.1042/BSR20190513 |
_version_ | 1783434038883647488 |
---|---|
author | Dai, Chang Gong, Qiaoyun Cheng, Yan Su, Guanfang |
author_facet | Dai, Chang Gong, Qiaoyun Cheng, Yan Su, Guanfang |
author_sort | Dai, Chang |
collection | PubMed |
description | Roundabout4 (Robo4) is a transmembrane receptor that belongs to the Roundabout (Robo) family of axon guidance molecules. Robo4 is an endothelial-specific receptor that participates in endothelial cell migration, proliferation, and angiogenesis and the maintenance of vasculature homeostasis. The purpose of this review is to summarize and analyze three main mechanisms related to the expression and function of Robo4 during developmental and pathological angiogenesis. In this review, static shear stress and the binding of transcription factors such as E26 transformation-specific variant 2 (ETV2) and Slit3 induce Robo4 expression and activate Robo4 during tissue and organ development. Robo4 interacts with Slit2 or UNC5B to maintain vascular integrity, while a disturbed flow and the expression of transcription factors in inflammatory or neoplastic environments alter Robo4 expression levels, although these changes have uncertain functions. Based on the mechanisms described above, we discuss the aberrant expression of Robo4 in angiogenesis-related diseases and propose antiangiogenic therapies targeting the Robo4 signaling pathway for the treatment of ocular neovascularization lesions and tumors. Finally, although many problems related to Robo4 signaling pathways remain to be resolved, Robo4 is a promising and potentially valuable therapeutic target for treating pathological angiogenesis and developmental defects in angiogenesis. |
format | Online Article Text |
id | pubmed-6620384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66203842019-07-24 Regulatory mechanisms of Robo4 and their effects on angiogenesis Dai, Chang Gong, Qiaoyun Cheng, Yan Su, Guanfang Biosci Rep Review Articles Roundabout4 (Robo4) is a transmembrane receptor that belongs to the Roundabout (Robo) family of axon guidance molecules. Robo4 is an endothelial-specific receptor that participates in endothelial cell migration, proliferation, and angiogenesis and the maintenance of vasculature homeostasis. The purpose of this review is to summarize and analyze three main mechanisms related to the expression and function of Robo4 during developmental and pathological angiogenesis. In this review, static shear stress and the binding of transcription factors such as E26 transformation-specific variant 2 (ETV2) and Slit3 induce Robo4 expression and activate Robo4 during tissue and organ development. Robo4 interacts with Slit2 or UNC5B to maintain vascular integrity, while a disturbed flow and the expression of transcription factors in inflammatory or neoplastic environments alter Robo4 expression levels, although these changes have uncertain functions. Based on the mechanisms described above, we discuss the aberrant expression of Robo4 in angiogenesis-related diseases and propose antiangiogenic therapies targeting the Robo4 signaling pathway for the treatment of ocular neovascularization lesions and tumors. Finally, although many problems related to Robo4 signaling pathways remain to be resolved, Robo4 is a promising and potentially valuable therapeutic target for treating pathological angiogenesis and developmental defects in angiogenesis. Portland Press Ltd. 2019-07-10 /pmc/articles/PMC6620384/ /pubmed/31160487 http://dx.doi.org/10.1042/BSR20190513 Text en © 2019 The Author(s). http://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Articles Dai, Chang Gong, Qiaoyun Cheng, Yan Su, Guanfang Regulatory mechanisms of Robo4 and their effects on angiogenesis |
title | Regulatory mechanisms of Robo4 and their effects on angiogenesis |
title_full | Regulatory mechanisms of Robo4 and their effects on angiogenesis |
title_fullStr | Regulatory mechanisms of Robo4 and their effects on angiogenesis |
title_full_unstemmed | Regulatory mechanisms of Robo4 and their effects on angiogenesis |
title_short | Regulatory mechanisms of Robo4 and their effects on angiogenesis |
title_sort | regulatory mechanisms of robo4 and their effects on angiogenesis |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620384/ https://www.ncbi.nlm.nih.gov/pubmed/31160487 http://dx.doi.org/10.1042/BSR20190513 |
work_keys_str_mv | AT daichang regulatorymechanismsofrobo4andtheireffectsonangiogenesis AT gongqiaoyun regulatorymechanismsofrobo4andtheireffectsonangiogenesis AT chengyan regulatorymechanismsofrobo4andtheireffectsonangiogenesis AT suguanfang regulatorymechanismsofrobo4andtheireffectsonangiogenesis |